Junxiang Wen

735 total citations
35 papers, 550 citations indexed

About

Junxiang Wen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Junxiang Wen has authored 35 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Junxiang Wen's work include Sarcoma Diagnosis and Treatment (11 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (6 papers). Junxiang Wen is often cited by papers focused on Sarcoma Diagnosis and Treatment (11 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (6 papers). Junxiang Wen collaborates with scholars based in China and United States. Junxiang Wen's co-authors include Qiyuan Bao, Yuhui Shen, Zhuochao Liu, Chuanzhen Hu, Weibin Zhang, Fangqiong Hu, Jizhuang Wang, Jun Wang, Liangzhi Gong and Yu Pei and has published in prestigious journals such as PLoS ONE, Small and Annals of Oncology.

In The Last Decade

Junxiang Wen

34 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junxiang Wen China 14 285 182 149 129 85 35 550
Berit M. Pfitzner Germany 11 243 0.9× 236 1.3× 126 0.8× 262 2.0× 72 0.8× 26 620
Hecheng Zhu China 14 295 1.0× 157 0.9× 96 0.6× 110 0.9× 132 1.6× 29 530
Aurélie Prignon France 15 249 0.9× 99 0.5× 83 0.6× 202 1.6× 58 0.7× 25 647
Guan Sun China 12 296 1.0× 246 1.4× 64 0.4× 134 1.0× 91 1.1× 16 565
Paulina Antosik Poland 11 183 0.6× 114 0.6× 88 0.6× 179 1.4× 52 0.6× 45 452
Masato Aragaki Japan 12 379 1.3× 121 0.7× 244 1.6× 177 1.4× 40 0.5× 48 683
Chen Zhu China 16 343 1.2× 208 1.1× 239 1.6× 180 1.4× 164 1.9× 35 680
Kirsten Lodder Netherlands 15 507 1.8× 185 1.0× 106 0.7× 176 1.4× 46 0.5× 25 698
Mengjun Ma China 14 382 1.3× 151 0.8× 51 0.3× 90 0.7× 75 0.9× 26 595

Countries citing papers authored by Junxiang Wen

Since Specialization
Citations

This map shows the geographic impact of Junxiang Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junxiang Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junxiang Wen more than expected).

Fields of papers citing papers by Junxiang Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junxiang Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junxiang Wen. The network helps show where Junxiang Wen may publish in the future.

Co-authorship network of co-authors of Junxiang Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Junxiang Wen. A scholar is included among the top collaborators of Junxiang Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junxiang Wen. Junxiang Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Chuanlong, Hongyi Wang, Qiyuan Bao, et al.. (2025). Chronic expanding hematomas arising over a decade post primary total hip arthroplasty. Journal of Orthopaedic Translation. 54. 199–213.
3.
Li, Meng, Qiyuan Bao, Zhuochao Liu, et al.. (2022). Exceptional response to PD-1 inhibition immunotherapy in advanced metastatic osteosarcoma with tumor site infection. Journal for ImmunoTherapy of Cancer. 10(9). e004673–e004673. 2 indexed citations
4.
Wang, Jizhuang, Fangqiong Hu, Yu Pei, et al.. (2022). Sorafenib inhibits doxorubicin-induced PD-L1 upregulation to improve immunosuppressive microenvironment in Osteosarcoma. Journal of Cancer Research and Clinical Oncology. 149(8). 5127–5138. 15 indexed citations
5.
Liu, Zhuochao, Jun Wang, Meng Li, et al.. (2022). DNA Base Pairing‐Inspired Supramolecular Nanodrug Camouflaged by Cancer‐Cell Membrane for Osteosarcoma Treatment. Small. 18(30). e2202337–e2202337. 24 indexed citations
6.
Li, Jing, Chenguang Zhao, Yuhuan Li, et al.. (2021). Osteosarcoma exocytosis of soluble LGALS3BP mediates macrophages toward a tumoricidal phenotype. Cancer Letters. 528. 1–15. 10 indexed citations
7.
Liu, Zhuochao, et al.. (2021). Exploration and Validation of a Novel Inflammatory Response-Associated Gene Signature to Predict Osteosarcoma Prognosis and Immune Infiltration. Journal of Inflammation Research. Volume 14. 6719–6734. 8 indexed citations
8.
Bao, Qiyuan, Zhuochao Liu, Junxiang Wen, et al.. (2021). Development and Validation of a Hypoxia-Associated Prognostic Signature Related to Osteosarcoma Metastasis and Immune Infiltration. Frontiers in Cell and Developmental Biology. 9. 633607–633607. 47 indexed citations
9.
Liu, Zhuochao, Hongyi Wang, Chuanzhen Hu, et al.. (2021). Targeting autophagy enhances atezolizumab-induced mitochondria-related apoptosis in osteosarcoma. Cell Death and Disease. 12(2). 164–164. 28 indexed citations
10.
Wang, Jun, et al.. (2020). Establishment of a dynamic osteosarcoma biobank: Ruijin experience. Cell and Tissue Banking. 21(3). 447–455. 7 indexed citations
11.
Qin, Jie, Rui Wang, Chenguang Zhao, et al.. (2019). Notch signaling regulates osteosarcoma proliferation and migration through Erk phosphorylation. Tissue and Cell. 59. 51–61. 29 indexed citations
12.
Yu, Pei, Junxiang Wen, Jun Wang, et al.. (2019). Establishment and characterization of a novel human osteosarcoma cell line for spontaneous pulmonary metastasis research in vivo. Annals of Translational Medicine. 7(20). 573–573. 6 indexed citations
14.
Hu, Chuanzhen, Yuhui Shen, Qiyuan Bao, et al.. (2018). Patellar height influences knee function in patients with aggressive bone tumors of the proximal tibia after endoprosthetic reconstruction. The Knee. 25(5). 952–958. 3 indexed citations
15.
Bao, Qiyuan, Liangzhi Gong, Jizhuang Wang, et al.. (2018). Extracellular Vesicle RNA Sequencing Reveals Dramatic Transcriptomic Alterations Between Metastatic and Primary Osteosarcoma in a Liquid Biopsy Approach. Annals of Surgical Oncology. 25(9). 2642–2651. 31 indexed citations
16.
Hu, Chuanzhen, Chen Xu, Junxiang Wen, et al.. (2017). Antitumor effect of focal adhesion kinase inhibitor PF 562271 against human osteosarcoma in vitro and in vivo. Cancer Science. 108(7). 1347–1356. 33 indexed citations
17.
Zhang, Weibin, Yuhui Shen, Yu Pei, et al.. (2016). Effects of resection margins on local recurrence of osteosarcoma in extremity and pelvis: Systematic review and meta-analysis. International Journal of Surgery. 36(Pt A). 283–292. 66 indexed citations
18.
Wen, Junxiang, Dongming Sun, Jun Tan, & Wise Young. (2014). A Consistent, Quantifiable, and Graded Rat Lumbosacral Spinal Cord Injury Model. Journal of Neurotrauma. 32(12). 875–892. 21 indexed citations
19.
Guo, Shuxiang, et al.. (2014). Giant delayed pseudo-aneurysm following screw placement in C1 lateral mass. Orthopaedics & Traumatology Surgery & Research. 100(6). 691–694. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026